Bustamante, Jhan G.
HRN: 23-24-90 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/03/2023
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
09/03/2023
09/09/2023
IV
65mg LD, 20mg Maintenance
OD
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes